FIELD: medicine, pharmaceutics.
SUBSTANCE: method for making a pharmaceutical composition in the form of a lozenge involves: (a) the preparation of a liquid composition including salt of a non-steroidal anti-inflammatory drug (salt of NSAID) and system of solvents, (b) the preparation of a fused composition to mould a lozenge, (c) mixing of the liquid composition and the fused composition to mould a lozenge, and (d) moulding of the lozenges of the prepared received mixture each containing a therapeutically effective amount of the specified mixture of salt of NSAID/NSAID. The compositions in the form of a lozenge under the invention are applied for treating throat inflammation.
EFFECT: use of salt of NSAID in a lozenge under the invention provides stability of a medicinal agent that allows to be combined with a wide spectrum of additives, including with aromatiSers.
35 cl, 6 tbl, 70 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR FLUBIPROPHEN TABLET MAKING | 1998 |
|
RU2203046C2 |
NSAID PREPARATION CONTAINING GRANULATED COMPOSITION AND EXTRA-GRANULATED COMPOSITION | 2002 |
|
RU2298404C2 |
THERAPEUTIC AGENTS | 2000 |
|
RU2246294C2 |
GRANULES CONTAINING NSAID AND SUGAR ALCOHOL PREPARED BY MELT EXTRUSION | 2005 |
|
RU2389480C2 |
THERAPEUTIC AGENTS | 2002 |
|
RU2301660C2 |
LOCAL COMPOSITION CONTAINING AMBROXOL | 2005 |
|
RU2381794C2 |
MICROCAPSULE-CONTAINING COMPOSITION | 2010 |
|
RU2509800C2 |
ORAL CARE COMPOSITIONS CONTAINING GEL MESH | 2007 |
|
RU2417071C2 |
CHEWING GUM AND CONFECTIONARY COMPOSITIONS CONTAINING ENDOTHERMIC AGENT | 2004 |
|
RU2313223C2 |
CONTROLLED RELEASE ANALGETIC SUSPENSIONS | 2004 |
|
RU2386434C2 |
Authors
Dates
2010-11-10—Published
2006-02-27—Filed